about
HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replicationHuman immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytesMolecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expressionHuman immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathwayPathogenesis of human immunodeficiency virus infectionThe defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesteraseCD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migrationRecent developments in human immunodeficiency virus-1 latency researchIdentification of a CD4 domain required for interleukin-16 binding and lymphocyte activationHIV-1 gp120-dependent induction of apoptosis in antigen-specific human T cell clones is characterized by 'tissue' transglutaminase expression and prevented by cyclosporin AThe CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migrationHIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cellsHuman-immunodeficiency-virus transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitroExtracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue.Preferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factorsInterference with the signaling capacity of CC chemokine receptor 5 can compromise its role as an HIV-1 entry coreceptor in primary T lymphocytes.Delayed human immunodeficiency virus type 1-induced apoptosis in cells expressing truncated forms of CD4.The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G proteinHuman immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion.Intercellular interactions in the recruitment and functions of human eosinophils.The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4.Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation.Antibodies against major histocompatibility complex class II antigens directly inhibit the growth of T cells infected with Theileria parva without affecting their state of activation.CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosisHIV-1 Nef increases T cell activation in a stimulus-dependent manner.Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes.An early postinfection signal mediated by monoclonal anti-beta 2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in peripheral blood mononuclear cellsInterleukin-16 as a marker of Sézary syndrome onset and stage.Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy.Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol.Impaired immunity in AIDS. The mechanisms responsible and their potential reversal by antiviral therapy.Immunology of HIV infection.The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cellsReproductive immunology of human immunodeficiency virus (HIV-1) infection.Role of CD4 in normal immunity and HIV infection.
P2860
Q24534883-9490E83F-C698-45FD-ABFF-2069200364F8Q24562117-A9AD0FA5-AFFF-4CF5-8145-7439A5C840AAQ24563012-940C8EEC-54A1-482C-BBA3-52748970D8DAQ24619935-5C8C8C96-B5A4-4BC6-BB0F-2EA8B1B43D3BQ24634681-ECD0C890-6E44-4992-A65F-F218E2980838Q24672173-D6A7F64F-E06A-4D2D-A5FF-A414115385FCQ24680875-436F3369-E414-4A6E-9F88-B0C317ADACA5Q27013114-B2C4415F-B7B3-4ED6-9C63-540424F29FA7Q28141470-2698EB0D-EFF4-4B17-892F-79D416E2CAECQ28237276-9FBBE0B1-26FB-4429-89AE-02E18AA03310Q28293638-0659AD1F-A323-4F5C-B407-18A4C6142B65Q28295622-599113EB-CA67-4838-B412-639AF98969BCQ28298228-9C53175F-7046-4E1D-9142-F0C851724089Q33687702-DC885F82-129A-4EA2-95F6-D94D62079538Q33724212-B570653E-5B14-4935-BB04-19952E6B4321Q33728885-D4BE1C16-A826-4075-AD1E-8952C54CD9DCQ33782246-D2B36FFD-5B4A-4CA6-ACEC-BC86B71562F2Q33785907-FACFFF29-C83B-45D2-8D0F-97D42412BC72Q34188750-DFF87289-38CB-41E3-81C6-1D8A3D62E5BFQ34225303-1546E467-8E37-4FE1-8709-536A12B7859CQ34574319-F31A3BF5-F78A-4547-ACD0-91CFBAA44C04Q35562932-7C0008CF-DDE4-4292-BEA5-817DC53ABF15Q35850502-CCB9D9BF-F51B-4E20-AC33-F2C25477BA7FQ35862050-6881B965-4308-4ACF-8FA6-D8F89285F752Q35980749-96CA32D4-11A2-4744-A7C1-5408D1553D4BQ36362189-9BF48329-EE12-450F-9490-5E64A9A49466Q36400376-7459BAE9-C149-441B-BDEB-699AAE1BDE64Q36418014-7C81182C-4321-4E8F-8EF9-D527DC2F80E5Q36656036-2765B525-263B-4E8D-BC96-B73DBC10DE8BQ36669879-7AE9343E-EC35-4A0C-8F68-DDCBE8580831Q36698842-B05AFF4F-67E7-42B3-A700-BC31DD0D01B9Q36803081-E832B10C-835F-44EF-9361-95E0C77E97ECQ36890797-C6388966-F418-424D-BCED-9E4562F87336Q37191908-4B47CE30-1AA2-42BD-B4EB-ED685FF78627Q37558221-56203DCF-BB2E-442D-AEEF-4F152CFF76BCQ37612103-365B471F-8A4A-44FD-ABE8-A54460FAF45DQ37615905-EAE04286-4FFD-4077-A155-2989EA9D47D2Q37638962-E681992C-6E48-4B33-9BC2-C49DC21BC806Q38025573-FE542A36-DA13-4DF8-8D07-809788211D51Q38206226-157D578B-F3F8-44D8-87F1-5E51A5210A70
P2860
description
1988 nî lūn-bûn
@nan
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
name
Lymphocyte activation by HIV-1 envelope glycoprotein
@ast
Lymphocyte activation by HIV-1 envelope glycoprotein
@en
Lymphocyte activation by HIV-1 envelope glycoprotein
@nl
type
label
Lymphocyte activation by HIV-1 envelope glycoprotein
@ast
Lymphocyte activation by HIV-1 envelope glycoprotein
@en
Lymphocyte activation by HIV-1 envelope glycoprotein
@nl
prefLabel
Lymphocyte activation by HIV-1 envelope glycoprotein
@ast
Lymphocyte activation by HIV-1 envelope glycoprotein
@en
Lymphocyte activation by HIV-1 envelope glycoprotein
@nl
P2093
P356
P1433
P1476
Lymphocyte activation by HIV-1 envelope glycoprotein
@en
P2093
D M Center
H Kornfeld
J S Berman
W W Cruikshank
P2888
P356
10.1038/335445A0
P407
P577
1988-09-29T00:00:00Z
P6179
1052829482